VURAL, E. Et Al. 2019. Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey. 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , (Stockholm, Sweden), 751.

VURAL, E., Terzi, M., SÜNTER, G., GÜNAL, D., Agan, K., & BOZ, C., (2019). Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey . 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS (pp.751). Stockholm, Sweden

VURAL, EZGİ Et Al. "Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey," 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 2019

VURAL, EZGİ Et Al. "Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey." 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , Stockholm, Sweden, pp.751, 2019

VURAL, E. Et Al. (2019) . "Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey." 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , Stockholm, Sweden, p.751.

@conferencepaper{conferencepaper, author={EZGİ VURAL Et Al. }, title={Real-life outcomes of Ocrelizumab treatment from 3 multiple sclerosis centers in Turkey}, congress name={35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS}, city={Stockholm}, country={Sweden}, year={2019}, pages={751} }